Pulmonary tuberculosis in a patient receiving intensive chemotherapy for metastatic breast cancer [4]

Breast Journal

Volumn 11, Issue 1, 2005, Pages 87-88

  Ito, Ken Ichi ^a   Fujimori, Minoru ^a   Shingu, Kiyoshi ^a   Hama, Yoshihisa ^a   Kanai, Toshiharu ^a   Koyama, Hiroshi ^a   Amano, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; EPIRUBICIN; FLUOROURACIL; ISONIAZID; MEDROXYPROGESTERONE ACETATE; PACLITAXEL; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC THERAPY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG HYPERSENSITIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION RISK; LETTER; LUNG CANCER; LUNG METASTASIS; LUNG TUBERCULOSIS; MASTECTOMY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; SPUTUM EXAMINATION; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, PULMONARY;

EID: 13444309079     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.21582.x     Document Type: Letter

References (10)

1. Belleza WG, Browne B. Pulmonary considerations in the immunocompromised patient. Emerg Med Clin N Am 2003;21:499-531.
2. Ortbals DW, Marr JJ. A comparative study of tuberculous and other mycobacterial infections and their associations with malignancy. Am Rev Respir Dis 1978;117:39-45.
3. Kaplan MH, Armstrong D, Rosen P. Tuberculosis complicating neoplastic disease: a review of 201 cases. Cancer 1974;33:850-58.
4. Klossek A, Dannenberg C, Feuerhahn MR, Korholz D. Pulmonary tuberculosis in a child receiving intensive chemotherapy for acute myeloblastic leukemia. J Pediatr Hematol Oncol 2004;26:64-67.
5. Skogberg K, Ruutu P, Tukiainen P, Valtnen V. Effect of immunosuppressive therapy on the clinical presentation and outcome of tuberculosis. Clin Infect Dis 1993;17:1012-17.
6. Stover DE, Kaner RJ. Pulmonary complications in cancer patients. CA Cancer J Clin 1996;46:303-20.
7. The National Institutes of Health Consensus Development Conference: Adjuvant Therapy for Breast Cancer. Bethesda, Maryland, USA. November 1-3, 2000. Proceedings. J Natl Cancer Inst Monogr 2001;30:5-15.
8. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003;21:3357-65.
9. Fossati R, Confalonieri C, Torri V, et al. Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol 1998;16:3439-60.
10. National Cancer Institute. Common Toxicity Criteria Manual, Version 2.0. Bethesda, MD: National Cancer Institute, June 1, 1999.